Market Tracker

09/22 5:16pm ET

Myriad Genetics Inc (NASDAQ:MYGN)

33.79
Delayed Data
As of 4:00pm ET
 +0.18 / +0.54%
Today’s Change
15.15
Today|||52-Week Range
33.90
+102.70%
Year-to-Date

Today’s Trading

Previous close33.61
Today’s open33.88
Day’s range33.52 - 33.90
Volume532,296
Average volume (3 months)1,013,526
Market cap$2.3B
Dividend yield--
Data as of 4:00pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)-81.29%
Earnings growth (this year)-3.08%
Earnings growth (next 5 years)+12.70%
Revenue growth (last year)+2.33%
P/E ratio105.6
Price/Sales2.30
Price/Book2.95

Competitors

 Today’s
change
Today’s
% change
AAAPAdvanced Accelerator...-2.10-3.67%
NEOGNeogen Corp+1.24+1.73%
IMMUImmunomedics Inc+0.02+0.17%
QDELQuidel Corp-0.03-0.07%
Data as of 4:00pm ET, 09/22/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)$0.21
Annual revenue (last year)$771.4M
Annual profit (last year)$21.8M
Net profit margin2.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts